Rethinking Remdesivir

San Diego Biotechnology Network
San Diego Biotechnology Network
Rethinking Remdesivir
Loading
/

UC San Diego researchers modify remdesivir, creating oral version that can be taken earlier in COVID-19 diagnoses. In cell and animal studies, revised drug proved effective and safe.

Click to view original post


ADVERTISEMENT — Advertise With Biotech Networks